Staidson (beijing) Biopharmaceuticals Co., Ltd
Clinical trials sponsored by Staidson (beijing) Biopharmaceuticals Co., Ltd, explained in plain language.
-
New eye drops aim to heal corneas in rare nerve disorder
Disease control Recruiting nowThis study tests an experimental eye drop called STSP-0902 for people with neurotrophic keratitis, a rare condition where the cornea loses sensation and can develop sores or ulcers. About 48 adults with moderate to severe disease will receive either the drug or a placebo for 8 we…
Phase: PHASE2 • Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 01, 2026 09:09 UTC
-
New injection for male infertility enters early human testing
Disease control Recruiting nowThis early-phase study tests a new drug called STSP-0902 in healthy men and men with low sperm count or poor sperm movement. The main goal is to check if the drug is safe and how the body processes it. The study is not designed to cure infertility, but to gather safety informatio…
Phase: PHASE1 • Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 01, 2026 09:09 UTC
-
New drug aims to save lives in severe lung failure
Disease control Recruiting nowThis study tests an experimental drug called STSA-1002 in 406 adults with acute respiratory distress syndrome (ARDS), a life-threatening lung condition often caused by viral infections. Participants receive either the drug or a placebo, and researchers track survival rates and re…
Phase: PHASE3 • Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC